5.10
Embecta Corp stock is traded at $5.10, with a volume of 1.54M.
It is down -0.20% in the last 24 hours and up +64.52% over the past month.
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.
See More
Previous Close:
$5.11
Open:
$5.16
24h Volume:
1.54M
Relative Volume:
0.73
Market Cap:
$288.96M
Revenue:
$1.04B
Net Income/Loss:
$111.90M
P/E Ratio:
2.5887
EPS:
1.9701
Net Cash Flow:
$205.80M
1W Performance:
+15.38%
1M Performance:
+64.52%
6M Performance:
-49.85%
1Y Performance:
-63.23%
Embecta Corp Stock (EMBC) Company Profile
Name
Embecta Corp
Sector
Industry
Phone
(862) 401-0000
Address
300 KIMBALL DRIVE, PARSIPPANY
Compare EMBC vs ISRG, BDX, ALC, RMD, MDLN
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
EMBC
Embecta Corp
|
5.10 | 269.13M | 1.04B | 111.90M | 205.80M | 1.9701 |
|
ISRG
Intuitive Surgical Inc
|
394.51 | 141.76B | 11.03B | 3.16B | 3.22B | 8.7251 |
|
BDX
Becton Dickinson Co
|
183.40 | 50.00B | 21.37B | 1.41B | 3.07B | 3.9437 |
|
ALC
Alcon Inc
|
74.25 | 35.57B | 10.63B | 819.00M | 1.59B | 1.6577 |
|
RMD
Resmed Inc
|
224.46 | 32.78B | 5.54B | 1.52B | 1.74B | 10.37 |
|
MDLN
Medline Inc
|
35.74 | 31.15B | 29.14B | 1.07B | 1.05B | 1.1956 |
Embecta Corp Stock (EMBC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-10-25 | Initiated | Mizuho | Neutral |
| Dec-02-24 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Nov-27-24 | Upgrade | BTIG Research | Neutral → Buy |
| Oct-20-23 | Initiated | Wolfe Research | Peer Perform |
| Jan-06-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Sep-08-22 | Initiated | BTIG Research | Neutral |
| Aug-01-22 | Initiated | Morgan Stanley | Equal-Weight |
| Jun-21-22 | Initiated | BofA Securities | Underperform |
View All
Embecta Corp Stock (EMBC) Latest News
Bronstein, Gewirtz & Grossman LLC Urges Embecta Corp. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire
EMBECTA CORP. DEADLINE MONDAY AUGUST 17th: Embecta Corp. - GlobeNewswire
CLASS ACTION DEADLINE MONDAY NIGHT: Faruqi & Faruqi, LLP Reminds Embecta (EMBC) Investors of Securities Class Action Lawsuit Deadline on August 17, 2026 - FinancialContent
Kaplan Fox Alerts Embecta Corp. (NASDAQ: EMBC) Investors Who Suffered Losses to a Securities Class Action – Deadline is August 17, 2026 - The Globe and Mail
EMBC Shareholder Alert: August 17, 2026 Lead Plaintiff - GlobeNewswire
Embecta Corp. SVP Elguicze purchases $93,360 in common stock By Investing.com - Investing.com South Africa
Embecta (EMBC) Q3 2026 Earnings Call Transcript - AOL.com
Embecta Corp. SVP Elguicze purchases $93,360 in common stock - Investing.com
Insider Spends US$141k Buying More Shares In Embecta - simplywall.st
Embecta CEO Devdatt Kurdikar buys $140,937 in company stock By Investing.com - Investing.com Canada
Embecta CEO Devdatt Kurdikar buys $140,937 in company stock - Investing.com
Embecta director Robert Hombach acquires $223.8k in common stock By Investing.com - Investing.com South Africa
Kaplan Fox Continues to Alert Investors of Embecta Corp. (NASDAQ - The National Law Review
Kaplan Fox Continues to Alert Investors of a Securities Class Act - The National Law Review
EMBC INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Embecta Corp. Shareholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
EMBC 4-DAY DEADLINE ALERT: Embecta Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitHagens Berman - TMX Newsfile
EMBC Shareholder Alert: Embecta Corp. Securities Class Action LawsuitInvestors With Losses May Contact SueWallSt - Morningstar
EMBC DEADLINE ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Embecta Corp. Investors to Secure ... - Caledonian Record
EMBC Deadline: Rosen Law Firm Urges Embecta Corp. (NASDAQ: EMBC) Stockholders to Contact the Firm for Information About Their Rights - Business Wire
Insider Buying: Embecta (NASDAQ:EMBC) CEO Acquires 30,000 Shares of Stock - MarketBeat
Insider Buying: Embecta (NASDAQ:EMBC) CFO Acquires $93,400.00 in Stock - MarketBeat
Jeffrey Mann Purchases 20,000 Shares of Embecta (NASDAQ:EMBC) Stock - MarketBeat
Embecta director Robert Hombach acquires $223.8k in common stock - Investing.com
Embecta Corp. (EMBC) CFO purchases 20,000 shares in open-market trade - Stock Titan
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Embecta Corp. of Class Action Lawsuit and Upcoming DeadlinesEMBC - PR Newswire
EMBC Investors Have Opportunity to Lead Embecta Corp. Securities Fraud Lawsuit with SBS Law - WBOC TV
EMBC INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announc - The National Law Review
EMBC Deadline: EMBC Investors with Losses in Excess of $100K Have Opportunity to Lead Embecta Corp. Securities Fraud Lawsuit - The Conway Daily Sun
EMBC STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Embecta Corp. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Lead Plaintiff Deadlines in Shareholder Class Action - GlobeNewswire
Kaplan Fox Reminds Embecta Corp. (NASDAQ: EMBC) Investors with Significant Losses to Seek a Leadership Role Before Deadline on August 17, 2026 - The Globe and Mail
EMBECTA CORP. INVESTORS WITH LOSSES HAVE UNTIL AUGUST 17, - GlobeNewswire
EMBC Securities Lawsuit: Embecta Securities Fraud Class - GlobeNewswire
EMBC 6-DAY DEADLINE ALERT: Embecta Corp. Investors with - GlobeNewswire
EMBC INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Stockholders of Embecta Corp. to Contact the Firm Today! - ACCESS Newswire
Deadline Alert: Embecta Corp. (EMBC) Shareholders Who Lost - GlobeNewswire
Embecta Corp. (EMBC) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
Embecta Corp. Notice of August 17, 2026 Application Deadline for Class Action LawsuitContact Reed Kathrein at Hagens Berman Sobol Shapiro LLP Before Application Deadline - Morningstar
Kaplan Fox Encourages Embecta Corp. (NASDAQ: EMBC) Investors to Contact the Firm Before the Lead Plaintiff Deadline on August 17, 2026 - FinancialContent
Portnoy Law Firm Announces Class Action on Behalf of Embecta Corp. Investors - GlobeNewswire
EMBC Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Embecta Corp. Securities LawsuitContact The Gross Law Firm - PR Newswire
EMBC Investor Announcement: Embecta Sued on behalf of Investors to Recover Losses after Insulin Pen Issues Lead to 57% Stock Drop - TradingView
Kaplan Fox Encourages Investors of Embecta Corp. (NASDAQ: EMBC) t - The National Law Review
EMBECTA DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, - GlobeNewswire
Kaplan Fox Encourages Investors of Embecta Corp. (NASDAQ: EMBC) to Contact the Firm Before Lead Plaintiff Deadline on August 17, 2026 - The Globe and Mail
Embecta Corp. Stockholders Have Until August 17th to Seek Lead Plaintiff Role with Bragar Eagel & Squire, P.C. - GlobeNewswire
Embecta adds to earnings rally with another 9% advance (EMBC:NASDAQ) - Seeking Alpha
EMBC INVESTOR ALERT: Embecta Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Morningstar
Embecta Q3 results beat analyst expectations - MassDevice
EMBC Stock – The Deadline to Move for Lead Plaintiff is - GlobeNewswire
Kaplan Fox & Kilsheimer LLP Alerts Embecta Corp. (NASDAQ: EMBC) Investors to a Securities ... - Caledonian Record
Embecta Corp Stock (EMBC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):